78 related articles for article (PubMed ID: 20374274)
1. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
Qian J; Qian Z; Lin J; Yao DM; Zhu ZH; Chen Q; Xiao GF; Li JY
Eur J Haematol; 2010 Aug; 85(2):174-6. PubMed ID: 20374274
[No Abstract] [Full Text] [Related]
2. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome.
Qian J; Zhu ZH; Lin J; Ming Yao DM; Li Y; Yang J; Wang CZ
Br J Haematol; 2011 Jul; 154(1):153-5. PubMed ID: 21517806
[No Abstract] [Full Text] [Related]
4. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
5. p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study.
Kim M; Oh B; Kim SY; Park HK; Hwang SM; Kim TY; She CJ; Yang I; Yoon SS; Yoon JH; Lee DS
Leuk Res; 2010 Jun; 34(6):718-22. PubMed ID: 19782398
[TBL] [Abstract][Full Text] [Related]
6. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome.
Bojesen SE; Ammerpohl O; Weinhäusl A; Haas OA; Mettal H; Bohle RM; Borkhardt A; Fuchs U
Br J Cancer; 2006 Jan; 94(2):323-32. PubMed ID: 16404424
[TBL] [Abstract][Full Text] [Related]
8. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
[TBL] [Abstract][Full Text] [Related]
10. Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.
Qian J; Qian Z; Lin J; Yao DM; Chen Q; Li Y; Ji RB; Yang J; Xiao GF; Wang YL
Leuk Res; 2011 Jun; 35(6):783-6. PubMed ID: 21074269
[TBL] [Abstract][Full Text] [Related]
11. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
12. GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies.
Qian Z; Qian J; Lin J; Yao DM; Chen Q; Ji RB; Li Y; Xiao GF; Li JY
J Exp Clin Cancer Res; 2010 Aug; 29(1):111. PubMed ID: 20704716
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias.
Yalcin A; Serin MS; Emekdas G; Tiftik N; Aslan G; Eskandari G; Tezcan S
Int J Lab Hematol; 2009 Aug; 31(4):407-19. PubMed ID: 18384396
[TBL] [Abstract][Full Text] [Related]
14. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
15. [Methylation status of RIZ1 gene promoter in myelodysplastic syndrome].
Xu RR; Xuan LN; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):774-5. PubMed ID: 23336240
[No Abstract] [Full Text] [Related]
16. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
17. Global increase in DNA methylation in patients with myelodysplastic syndrome.
Römermann D; Hasemeier B; Metzig K; Göhring G; Schlegelberger B; Länger F; Kreipe H; Lehmann U
Leukemia; 2008 Oct; 22(10):1954-6. PubMed ID: 18385753
[No Abstract] [Full Text] [Related]
18. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
Hasegawa D; Manabe A; Kubota T; Kawasaki H; Hirose I; Ohtsuka Y; Tsuruta T; Ebihara Y; Goto Y; Zhao XY; Sakashita K; Koike K; Isomura M; Kojima S; Hoshika A; Tsuji K; Nakahata T
Br J Haematol; 2005 Mar; 128(6):805-12. PubMed ID: 15755284
[TBL] [Abstract][Full Text] [Related]
20. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
